-
UltraTech Cem.
11,575.00 10,329.00(%) -
JSW Energy
562.05 617.30(%) -
Urban Company
146.00 201.00(%) -
HDFC Bank
724.45 722.00(%) -
ICICI Bank
1,406.60 1,187.55(%) -
Reliance Industries
1,307.10 1,250.55(%) -
Larsen & Toubro
4,070.00 4,440.00(%) -
Bharti Airtel
1,970.05 2,174.70(%) -
Godrej Consumer
938.90 1,308.40(%) -
Netweb Technol.
5,200.00 5,241.65(%) -
Thyrocare Tech.
594.30 342.55(%) -
Fortis Health.
904.95 1,105.00(%) -
SBI
1,073.20 798.60(%) -
Astral
1,599.00 1,767.95(%) -
M & M
3,440.00 3,840.00(%) -
ITC
279.50 426.50(%) -
Cupid
295.00 295.00(%) -
Bajaj Finserv
2,037.00 2,194.65(%) -
Axis Bank
1,215.30 1,041.30(%) -
Solar Industries
20,400.00 20,400.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aspira Pathlab & Diagnostics Ltd Healthcare
- Indian Private
- BSE Code : 23958.0
- ISIN : INE500C01017
-
Today’s Low
101.00 -
Today’s High
101.50
-
Open
101.00 -
Perv Close
100.70 -
52W Low
49.00 -
52W High
135.88
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
104.47
-
Div & Yield %
0.00
-
Book Value(₹)
11.88
-
Debt-Equity Ratio
0.79
-
AGM Date
13-Aug-2026
-
EPS
0.05
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
104.47
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
10.29
-
BV (₹)
11.90
-
Sales( ₹ in Cr.)
24.98
-
NP (in Cr.)
0.05
-
NP Var(%)
-98.0
-
Div%
0.0
-
CPS (₹)
1.50
-
EPS (₹)
0.00
-
Traded Value (₹ in Lakhs)
103.65
-
52 Week High
135.88
-
52 Week Low
49.00
-
Price BSE
101.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
103.65
-
P/C Ratio
65.40
-
P/E Ratio
2,026.50
-
Price Vs.BV
0.00
-
06-Aug-2026( 05:05)
Corporate News - Aspir... - Aspira Pathlab & Diagnostics L...
-
25-May-2026( 07:43)
Results - Announcements - Aspir... - Net loss of Aspira Pathlab & D...
-
19-May-2026( 12:58)
Corporate News - Aspir... - Aspira Pathlab & Diagnostics w...
-
11-Feb-2026( 07:48)
Results - Announcements - Aspir... - Net loss of Aspira Pathlab & D...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 22.00 | 13.20 | 14.46 | 19.54 | 15.21 | 8.42 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 22.00 | 13.20 | 14.46 | 19.54 | 15.21 | 8.42 |
| Other Income | 0.39 | 0.42 | 0.32 | 0.09 | 0.20 | 0.29 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 22.39 | 13.62 | 14.78 | 19.63 | 15.41 | 8.71 |
| EXPENDITURE : | ||||||
| Raw Materials | 3.70 | 2.62 | 2.50 | 3.14 | 2.63 | 1.99 |
| Power and Fuel Cost | 0.33 | 0.26 | 0.24 | 0.21 | 0.13 | 0.32 |
| Employee Cost | 7.33 | 6.20 | 5.59 | 5.02 | 4.03 | 4.95 |
| Other Manufacturing Expenses | 1.87 | 0.97 | 1.91 | 1.40 | 2.64 | 0.97 |
| Selling and Administration Expenses | 3.69 | 3.43 | 2.59 | 2.94 | 2.16 | 1.92 |
| Miscellaneous Expenses | 1.56 | 0.92 | 0.03 | 0.46 | 0.10 | 0.11 |
| Employee Benefit Expenses | 7.33 | 6.20 | 5.59 | 5.02 | 4.03 | 4.95 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 18.48 | 14.39 | 12.87 | 13.17 | 11.69 | 10.25 |
| Operating Profit | 3.92 | -0.76 | 1.92 | 6.47 | 3.72 | -1.54 |
| Interest | 0.35 | 0.37 | 0.42 | 0.37 | 0.89 | 1.01 |
| Gross Profit | 3.57 | -1.13 | 1.50 | 6.10 | 2.83 | -2.55 |
| Depreciation | 1.49 | 1.54 | 1.59 | 1.64 | 1.44 | 1.66 |
| Profit Before Tax | 2.08 | -2.67 | -0.09 | 4.46 | 1.39 | -4.21 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 2.07 | -2.67 | -0.09 | 4.46 | 1.38 | -4.24 |
| Extraordinary Items | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 2.10 | -2.67 | -0.09 | 4.46 | 1.38 | -4.24 |
| Adjustment below Net Profit | 0.00 | 0.07 | 0.05 | 0.02 | 0.13 | -0.01 |
| P & L Balance brought forward | -14.11 | -11.50 | -11.46 | -15.94 | -17.45 | -13.20 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -12.04 | -14.11 | -11.50 | -11.46 | -15.94 | -17.45 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 | -4.56 |
| Earnings Per Share(Adj)-Unit Curr | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 | -4.56 |
| Book Value | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 | -1.21 |
| Book Value(Adj)-Unit Curr | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 | -1.21 |
